Afficher la notice abrégée

dc.contributor.authorDe Vita, Dalila
dc.date.accessioned2022-06-02T04:08:16Z
dc.date.available2022-06-02T04:08:16Z
dc.date.issued2021
dc.date.submitted2022-05-31T10:37:44Z
dc.identifierONIX_20220531_9788855183444_980
dc.identifier2612-8020
dc.identifierhttps://library.oapen.org/handle/20.500.12657/55696
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/82317
dc.description.abstractMalformations of cortical development (MCDs) result from a disruption in the process of the human brain cortex formation: currently, there are no pharmacological treatments for diffuse MCDs. Next-generation sequencing has accelerated the identification of MCDs causing genes: in some cases, functional studies are needed to clarify the role of genetic variants. The aim of this PhD project has been to apply a multidisciplinary approach to identify causative mutations in patients with MCDs, validate the pathogenic role of the identified mutations, and assess the effectiveness of novel in vitro treatment for mTOR pathway related MCDs.
dc.languageEnglish
dc.relation.ispartofseriesPremio Tesi di Dottorato
dc.rightsopen access
dc.subject.otherMCDs
dc.subject.otherEpilepsy
dc.subject.otherNGS
dc.subject.otherfibroblasts
dc.subject.othermetformin
dc.titleFunctional validation of genetic variants identified by next generation sequencing in malformations of cortical development
dc.typebook
oapen.identifier.doi10.36253/978-88-5518-344-4
oapen.relation.isPublishedBy2ec4474d-93b1-4cfa-b313-9c6019b51b1a
oapen.relation.isbn9788855183444
oapen.relation.isbn9788855183437
oapen.relation.isbn9788855183451
oapen.pages66
oapen.place.publicationFlorence
dc.seriesnumber88


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

open access
Excepté là où spécifié autrement, la license de ce document est décrite en tant que open access